Comparative efficacy and safety of preventive treatment with cytovir-3 and arbidol in children during seasonal outbreak of respiratory viral infection (an open-label randomized clinical study)
Aim: To compare the safety and prophylactic efficacy of Cytovir-3 and Arbidol in an open-label randomized clinical trial in children at seasonal risk of infectious respiratory disease.Methods: This study was performed in the period preceding a seasonal outbreak of acute respiratory viral infections...
Guardado en:
Autores principales: | V. S. Smirnov, S. A. Saveliev, S. V. Petlenko, G. Redlich, M. K. Erofeeva, A. V. Lyovina, N. I. Zavialova |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
Sankt-Peterburg : NIIÈM imeni Pastera
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e2ce4ea93b604997b599b9daa9e85133 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy and safety of arbidol (umifenovir) in patients with COVID‐19: A systematic review and meta‐analysis
por: Behnam Amani, et al.
Publicado: (2021) -
SUMMARY OF INFLUENZA AND OTHER RESPIRATORY VIRUSES DETECTED AND CHARACTERIZED IN RUSSIA DURING 2017–2018 SEASON
por: A. A. Sominina, et al.
Publicado: (2018) -
Opportunities for immunocorrection aiming for reduction of morbidity in the areas with adverse occupational and environmental conditions
por: S. V. Petlenko, et al.
Publicado: (2021) -
Detection of influenza virus and pathogens of acute respiratory viral infections in population of Kazakhstan during 2018-2019 epidemic season
por: N. G. Klivleyeva, et al.
Publicado: (2021) -
Some opportunities for immunotherapy in coronavirus infection
por: V. S. Smirnov, et al.
Publicado: (2020)